Magrolimab plus Azacitidine for Myelodysplastic Syndrome

Video

Drs Stein and Carraway explain the rationale for a magrolimab and azacitidine combination treatment for patients with higher-risk MDS with supporting data from 2 clinical trials.

Related Videos
Jamie Koprivnikar, MD, and Hana Safah, MD, experts on MDS
Jamie Koprivnikar, MD, and Hana Safah, MD, experts on MDS
Jamie Koprivnikar, MD, and Hana Safah, MD, experts on MDS
Related Content